# Effect of F. Prausnitzii on Glycemic Control

> **NCT04938843** · NA · UNKNOWN · sponsor: **MetaboGen AB** · enrollment: 176 (estimated)

## Conditions studied

- Pre Diabetes
- Impaired Glucose Tolerance
- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** F. prausnitzii and D. piger
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04938843
- **Lead sponsor:** MetaboGen AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-16
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2021-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04938843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04938843, "Effect of F. Prausnitzii on Glycemic Control". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04938843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*